Substantial health and economic burden of COVID-19 during the year after acute illness among US adults not at high risk of severe COVID-19

Amie Scott,Wajeeha Ansari,Richard Chambers,Maya Reimbaeva,Tomasz Mikolajczyk,Michael Benigno,Florin Draica and Joanna Atkinson
DOI: https://doi.org/10.1186/s12916-023-03235-5
IF: 9.3
2024-02-04
BMC Medicine
Abstract:Patients recovering from SARS-CoV-2 infection and acute COVID-19 illness can experience a range of long-term post-acute effects. The potential clinical and economic burden of these outcomes in the USA is unclear. We evaluated diagnoses, medications, healthcare utilization, and medical costs before and after acute COVID-19 illness in US patients who were not at high risk of severe COVID-19.
medicine, general & internal
What problem does this paper attempt to address?